Is Etelcalcetide legal in the US?
Yes, FDA approved for high parathyroid hormone in adults on dialysis.
AStrong human evidenceFDA approvedas of 2026-10-26
Approved. Etelcalcetide was approved by the FDA in February 2017 as Parsabiv (Amgen) for secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis. It is given intravenously through the dialysis circuit at the end of a session. 2
Yes. Parsabiv was approved in 2017. It treats secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis. 2
Read the full Etelcalcetide page
More on Etelcalcetide
Citations
- Block 2017, JAMA: effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism doi.org
- Amgen: Parsabiv (etelcalcetide) prescribing information pi.amgen.com
Reference information only, not medical advice. Drawn from the Etelcalcetide article, fact-checked against the cited sources. No dosing anywhere on this site.